摘要
年龄和合并症是 COVID-19 患者住院、严重疾病和死亡率的关键指标。患有心血管疾病、高血压、糖尿病、慢性肾病、NAFLD、肥胖和代谢综合征等与年龄相关的合并症的患者更有可能需要住院并患上 COVID-19 重症。患有阿尔茨海默病和与痴呆相关的危险因素的患者也可能更容易受到严重的 COVID-19 感染。外周炎症,包括从疾病中康复的患者,可能通过神经炎症通路促进神经退行性疾病的进程。本研究的目的是检查 COVID-19 对代谢综合征和阿尔茨海默病等年龄相关疾病患者免疫力的影响,并假设代谢综合征、阿尔茨海默病和 COVID-19 之间可能存在相关性。确定解释代谢综合征、阿尔茨海默病、COVID-19、炎症和免疫之间复杂相互作用的机制对于设计有效的药物疗法和程序至关重要。这项研究通过综合这些联系的当前知识,增加了我们关于新冠状病毒的基本信息。为了减少炎症和增强免疫力,患者应该养成良好的生活方式。散步、呼吸运动和营养丰富的饮食都有助于提高肺活量和免疫力。本文鼓励对代谢综合征、阿尔茨海默病和 COVID-19 炎症和免疫学患者的新疗法进行未来研究。
关键词: 代谢综合征、阿尔茨海默病、COVID-19、炎症、免疫、肥胖、NAFLD、痴呆。
Current Alzheimer Research
Title:Metabolic Syndrome, Alzheimer’s Disease, and Covid 19: A Possible Correlation
Volume: 18 Issue: 12
关键词: 代谢综合征、阿尔茨海默病、COVID-19、炎症、免疫、肥胖、NAFLD、痴呆。
摘要:
Age and comorbidities are key indicators of hospital admission, serious illness, and mortality in COVID-19 patients. Patients with age-related comorbidities, such as cardiovascular disease, hypertension, diabetes, chronic kidney disease, NAFLD, obesity, and metabolic syndrome, are more likely to require hospitalization and suffer severe sickness of COVID-19. Patients with Alzheimer’s disease and risk factors associated with dementia may also be more vulnerable to serious COVID-19 infection. Peripheral inflammation, including in patients who recover from illness, may promote the course of neurodegenerative disorders through neuroinflammatory pathways.
The aim of this study is to examine the impact of COVID-19 on immunity in patients with age-related diseases such as metabolic syndrome and Alzheimer’s disease and also to hypothesize the possible correlation between metabolic syndrome, Alzheimer’s disease, and COVID-19. Identifying the mechanisms that explain the complicated interaction between metabolic syndrome, Alzheimer’s disease, COVID-19, inflammation, and immunity could be crucial to designing effective pharmacological therapies and procedures. This study adds to our basic information about the new coronavirus by synthesizing current knowledge of these linkages. To reduce inflammation and enhance immunity, patients should acquire good lifestyle practices. Walking, breathing exercises, and a nutritious diet all help in improving lung capacity and immunity.
Future research into novel therapeutics for patients with metabolic syndrome, Alzheimer’s disease, and COVID-19 inflammation and immunology is encouraged by this paper.
Export Options
About this article
Cite this article as:
Metabolic Syndrome, Alzheimer’s Disease, and Covid 19: A Possible Correlation, Current Alzheimer Research 2021; 18 (12) . https://dx.doi.org/10.2174/1567205018666211209095652
DOI https://dx.doi.org/10.2174/1567205018666211209095652 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments
Current Drug Targets Successfully Resuscitated Sudden Cardiac Death in a Young Homosexual Male with HIV Myocarditis
Current HIV Research Platelet Turnover in Atherothrombotic Disease
Current Pharmaceutical Design Electroacupuncture Reduces Hemiplegia Following Acute Middle Cerebral Artery Infarction with Alteration of Serum NSE, S-100B and Endothelin
Current Neurovascular Research Molecular Imaging of Vascular Thrombosis
Current Molecular Imaging (Discontinued) Surgical Treatment of the Sleep Apnea Syndrome in the Twenty-First Century
Current Respiratory Medicine Reviews Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design Schiff Bases of Isatin: Inhibitory Potential Towards Acetylcholinesterase and Butyrylcholinesterase
Letters in Drug Design & Discovery Target Recognition Molecules and Molecular Modeling Studies
Current Topics in Medicinal Chemistry Modulation of Interleukin-10 Production by Therapeutic Drugs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Treating COPD in Older and Oldest Old Patients
Current Pharmaceutical Design Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Surgery for Severe Obesity: Indications, Techniques, Mechanisms of Weight Loss and Diabetes Resolution
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement
Current Medicinal Chemistry Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Current Neuropharmacology Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
Current Medicinal Chemistry The HIV Life Cycle: Multiple Targets for Antiretroviral Agents
Drug Design Reviews - Online (Discontinued) Liquid Chromatography-Tandem Mass Spectrometry to Monitor Unbound and Total Ceftriaxone in Serum of Critically Ill Patients
Current Reviews in Clinical and Experimental Pharmacology Contemporary Overview on Clinical Trials and Future Prospects of Hepato-protective Herbal Medicines
Reviews on Recent Clinical Trials Modulation of Protein-Protein Interactions by Stabilizing/Mimicking Protein Secondary Structure Elements
Current Topics in Medicinal Chemistry